Karmanos Cancer Institute First in the World to use FDA-approved Radiofrequency Electromagnetic Device to Treat Liver Cancer
On Dec. 18, 2024, the Barbara Ann Karmanos Cancer Institute announced that the new TheraBionic P1 device, an…
On Dec. 18, 2024, the Barbara Ann Karmanos Cancer Institute announced that the new TheraBionic P1 device, an…
On Nov. 21, 2024, the U.S. Centers for Disease Control and Prevention (CDC) reported that by the week…
On Nov. 20, 2024, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
On Nov. 6, 2024, a trio of new studies with funding from Cancer Grand Challenges revealed the unfair advantage…
On Nov. 5, 2024, a cross-sectional study of data for 36 cancer types from 185 countries and territories…
On Oct. 30, 2024, ten studies from the Human Tumor Atlas Network (HTAN), a National Institutes of Health…
On Oct. 29, 2024, a study led by Andrei Gudkov, PhD, DSci, at Roswell Park Comprehensive Cancer Center support…
On Oct. 2, 2024, results from a French clinical trial have identified what experts say should now be…
On Sept. 24, 2024, researchers at the National Institutes of Health (NIH) reported results of a study that…
On Aug. 21, 2024, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
On Aug. 15, 2024, researcher from from Western University announced they had discovered a protein that has the…
On Aug. 15, 2024, a study published in the journal Cancer projected an alarming increase in cancer cases and deaths…
On Aug. 13, 2024, President Joe Biden announced $150 million in awards from the Advanced Research Projects Agency…
On Aug. 6, 2024, the U.S. Food and Drug Administration (FDA) announced it had approved vorasidenib (Voranigo, Servier…
On Aug. 5, 2024, Novartis and Viatris were named a federal lawsuit in Maryland by the family of…
On Aug. 2, 2024, the U.S. Food and Drug Administration approved Adaptimmune’s Tecelra (afamitresgene autoleucel), a gene therapy…
On Jul. 29, 2024, a team led by the Barbara Ann Karmanos Cancer Institute and the Wayne State…
On Jul. 26, 2024, the U.S. Food and Drug Administration (FDA) approved the Guardant Health’s Shield, a test…
On Jul. 17, 2024, the National Cancer Institute (NCI) announced that a study, funded in part by the…
On Jun. 28, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
On May 15, 2024, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
On May 14, 2024, Roche announced the U.S. FDA approval of its human papillomavirus (HPV) self-collection solution, one…
“Say I Don’t Smoke, You’ll be in Good Company” was published by the Irish Cancer Society (ca. 1987).
“Break the Habit!,” A quit smoking poster published by the New York State Department of Health, 1989.
On May 1, 2024, researchers at the National Institutes of Health (NIH) announced a review in JAMA that…
On Apr. 26, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had approved awarding nearly $31…
On Mar. 18, 2024, the U.S. Environmental Protection Agency (EPA) announced a final rule to prohibit ongoing uses…
On Feb. 23, 2024, the California Institute for Regenerative Medicine (CIRM) awarded $56 million to fund various clinical…
On Feb. 21, 2024, the National Institutes of Health (NIH) announced it had launched a clinical trials network…
On Feb. 21, 2024, the Fred Hutchinson Cancer Center announced it was at the helm of a new…